Nucleic Acids Research, 2003, Vol. 31, No. 15 4326-4331
© 2003 Oxford University Press
Solution structure of the HIV-1 frameshift inducing stemloop RNA
Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, WI 53706, USA
*To whom correspondence should be addressed. Tel: +1 608 263 3890; Fax: +1 608 262 3453; Email: butcher{at}nmrfam.wisc.edu
The translation of reverse transcriptase and other essential viral proteins from the HIV-1 Pol mRNA requires a programmed 1 ribosomal frameshift. This frameshift is induced by two highly conserved elements within the HIV-1 mRNA: a slippery sequence comprised of a UUUUUUA heptamer, and a downstream stemloop structure. We have determined the structure of the HIV-1 frameshift inducing RNA stemloop, using multidimensional heteronuclear nuclear magnetic resonance (NMR) methods. The 22 nucleotide RNA solution structure [root mean squared deviation (r.m.s.d.) = 1.2 Å] was determined from 475 nuclear Overhauser effect (NOE)-derived distance restrains, 20 residual dipolar couplings and direct detection of hydrogen bonds via scalar couplings. We find that the frameshift inducing stemloop is an A-form helix capped by a structured ACAA tetraloop. The ACAA tetraloop is stabilized by an equilateral 5' and 3' stacking pattern, a sheared AA pair and a cross-strand hydrogen bond. Unexpectedly, the ACAA tetraloop structure is nearly identical to a known tetraloop fold, previously identified in the RNase III recognition site from Saccharomyces cerevisiae.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
V. Venditti, N. Niccolai, and S. E. Butcher Measuring the dynamic surface accessibility of RNA with the small paramagnetic molecule TEMPOL Nucleic Acids Res., March 27, 2008; 36(4): e20 - e20. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Girnary, L. King, L. Robinson, R. Elston, and I. Brierley Structure-function analysis of the ribosomal frameshifting signal of two human immunodeficiency virus type 1 isolates with increased resistance to viral protease inhibitors J. Gen. Virol., January 1, 2007; 88(1): 226 - 235. [Abstract] [Full Text] [PDF] |
||||

